在结肠直肠癌的进展和转移过程中,尼多根-1/NID1的功能和调节
Matjaz Rokavec1, Stephanie Jaeckel1, Heiko Hermeking1,2,3
1Experimental and Molecular Pathology, Institute of Pathology, Medical Faculty, Ludwig-Maximilians-Universität München, D-80337 Munich, Germany.
尼多根1 (NID1) 通过诱导上皮层-介质细胞过渡 (EMT) 来促进结直肠癌 (CRC) 的进展和转移. 准NID1受体ITGAV可能为高级CMS4CRC瘤提供治疗策略.
科学领域:
- 分子瘤学分子瘤学
- 癌症转移 癌症转移
- 细胞外矩阵生物学 细胞外矩阵生物学
背景情况:
- 结肠直肠癌 (CRC) 细胞表现出不同的恶性瘤,更具攻击性的细胞分泌细胞外基因蛋白.
- 基底膜蛋白Nidogen1 (NID1) 之前已被认为有助于促进癌细胞迁移和入侵.
研究的目的:
- 研究NID1及其受体在结直肠癌 (CRC) 进展和转移中的作用.
- 阐明NID1和上皮层-介质细胞转换 (EMT) 途径之间的调节关系.
- 在特定的CRC亚型中识别潜在的治疗点.
主要方法:
- 对CRC患者数据集的全面生物信息学分析.
- 评估基因表达与预后和瘤阶段的相关性.
- 实验室内研究涉及小鼠外宫基因表达和异种移植模型.
主要成果:
- 增加NID1及其受体 (ITGA3,ITGB1,ITGAV) 的表达与预后不佳和晚期CRC相相关.
- NID1表达与EMT签名相关,NID1被确定为EMT诱导转录因子SNAIL的直接目标.
- 在体内,NID1促进CRC转移到肺部,抑制NID1受体ITGAV降低了细胞活力,特别是在CMS4CRC中.
结论:
- NID1是一个直接的SNAIL目标,驱动CRC进展和转移.
- NID1受体ITGAV是CMS4结直肠瘤的潜在治疗标.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
11:43Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
